Research and Development

A consortium of big pharma companies and university with world-leading medical research facilities is to invest £40 million, to “significantly …

AbbVie has announced a new partnership with The University of Texas MD Anderson Cancer Centre, using its immunotherapy platform to …

Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …

Merck has appointed Jessie English as the new vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. …

Five people have been charged in the US for a scheme to steal secrets from British drugmaker GlaxoSmithKline and then …

More than 70 leading international pharmaceutical and biotechnology companies, as well as industry associations, have come together to call for …

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof  an Ebola virus vaccine, to …

Eli Lilly has submitted a new drug application (NDA) to the FDA for baricitinib as a treatment for moderate-to-severe rheumatoid …

The FDA has signed-off a supplemental Biologics License Application (sBLA), meaning Arzerra is approved for extended treatment of patients who …

Johnson & Johnson has announced a restructuring of its medical devices business unit that could result in up to 3,000 …

Days after the clinical trial accident that left one participant dead and five hospitalised with neurological problems, French Health Minister …

Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …

Novartis has won FDA approval for Cosentyx (secukinumab) for the treatment of two new indications – adults with active ankylosing …

A study by Eleven Biotherapeutics to prove the clinical value of its eye drug isunakinra has flopped, after the drug …